3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs

NCT00718861 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Post-menopausal Osteoporosis

Interventions

DRUG: Placebo
DRUG: Zoledronic acid

Sponsor

Novartis Pharmaceuticals